(Q35844052)

English

Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial

scientific article published on 19 October 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial (English)

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Alan Pollack

1

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Alexandra L Hanlon

2

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Eric M Horwitz

3

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Steven J Feigenberg

4

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Andre A Konski

5

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Benjamin Movsas

6

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Richard E Greenberg

7

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Robert G Uzzo

8

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

C-M Charlie Ma

9

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Shawn W McNeeley

10

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Mark K Buyyounouski

11

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Robert A Price

12

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

language of work or name

0 references

publication date

19 October 2005

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

64

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

518-526

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892754

11 July 2018

Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892754

11 July 2018

Radiation therapy dose escalation for prostate cancer: a rationale for IMRT.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892754

11 July 2018

Impact of androgen deprivation therapy on survival in men treated with radiation for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892754

11 July 2018

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892754

11 July 2018

Is alpha/beta for prostate tumors really low?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892754

11 July 2018

Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892754

11 July 2018

Acute toxicity of three-dimensional conformal radiotherapy in prostate cancer patients eligible for implant monotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892754

11 July 2018

Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892754

11 July 2018

Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892754

11 July 2018

Carcinoma of the prostate: results of radical radiotherapy (1970-1985).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892754

11 July 2018

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892754

11 July 2018

Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892754

24 September 2018

Hypofractionated conformal radiotherapy in carcinoma of the prostate: five-year outcome analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892754

24 September 2018

A method for increased dose conformity and segment reduction for SMLC delivered IMRT treatment of the prostate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892754

24 September 2018

Reduction in acute morbidity using hypofractionated intensity-modulated radiation therapy assisted with a fluoroscopic real-time tumor-tracking system for prostate cancer: preliminary results of a phase I/II study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892754

24 September 2018

Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha/beta ratio.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892754

24 September 2018

Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892754

24 September 2018

Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892754

24 September 2018

Dose-volume relationship for acute side effects during high dose conformal radiotherapy for prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892754

24 September 2018

Short-course, intensity-modulated radiotherapy for localized prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892754

24 September 2018

Is the alpha/beta ratio for prostate cancer low?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892754

24 September 2018

Chronic radiation damage in the rat rectum: an analysis of the influences of fractionation, time and volume.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892754

24 September 2018

Radiation tolerance of the rat rectum to fractionated X-rays and pi-mesons

1 reference

https://pubmed.ncbi.nlm.nih.gov/16242256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha/beta value and importance of dose per fraction for the late rectal and recto-sigmoid complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/16242256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/16242256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel

1 reference

https://pubmed.ncbi.nlm.nih.gov/16242256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fractionation and protraction for radiotherapy of prostate carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16242256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fractionation and late rectal toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/16242256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/16242256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early and late injuries in mouse rectum after fractionated X-ray and neutron irradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16242256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique

1 reference

https://pubmed.ncbi.nlm.nih.gov/16242256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retrospective study of radiotherapy in early carcinoma of the prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/16242256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is the prostrate alpha/beta ratio of 1.5 from Brenner & Hall a modeling artifact

1 reference

https://pubmed.ncbi.nlm.nih.gov/16242256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16242256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low

1 reference

https://pubmed.ncbi.nlm.nih.gov/16242256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/16242256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16242256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16242256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Yes, the alpha/beta ratio for prostate cancer is low or "methinks the lady doth protest too much...about a low alpha/beta that is"

1 reference

https://pubmed.ncbi.nlm.nih.gov/16242256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16242256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How low is the alpha/beta ratio for prostate cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16242256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How low is the alpha/beta ratio for prostate cancer? In regard to Wang et al., IJROBP 2003;55:194-203

1 reference

https://pubmed.ncbi.nlm.nih.gov/16242256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of alpha/beta estimates from homogeneous (individual) and heterogeneous (population) tumor control models for early stage prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16242256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate cancer radiotherapy dose response: an update of the fox chase experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/16242256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16242256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of a simultaneous boost IMRT class solution for a hypofractionated prostate cancer protocol

1 reference

https://pubmed.ncbi.nlm.nih.gov/16242256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.IJROBP.2005.07.970

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35844052&oldid=1767022166"